DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hoeltzenbein M, Beck E, Meixner K, Schaefer C, Kreutz R.
Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre.
Clin Res Cardiol 2016;
105 (02) 117-126
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.